$330 Million is the total value of Nextech Invest Ltd.'s 14 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | TANGO THERAPEUTICS INC | $62,312,615 | – | 5,533,980 | +100.0% | 18.88% | – | |
| RLAY | Buy | RELAY THERAPEUTICS INC | $10,061,800 | -15.6% | 1,196,409 | +26.1% | 3.05% | -24.7% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| REVOLUTION MEDICINES INC | 8 | Q3 2023 | 44.0% |
| EQRX INC | 8 | Q3 2023 | 23.5% |
| TYRA BIOSCIENCES INC | 8 | Q3 2023 | 16.9% |
| KINNATE BIOPHARMA INC | 8 | Q3 2023 | 14.0% |
| CULLINAN ONCOLOGY INC | 8 | Q3 2023 | 5.3% |
| PMV PHARMACEUTICALS INC | 8 | Q3 2023 | 8.4% |
| ARVINAS INC | 8 | Q3 2023 | 6.2% |
| SILVERBACK THERAPEUTICS INC | 8 | Q3 2023 | 6.5% |
| KRONOS BIO INC | 8 | Q3 2023 | 5.2% |
| THESEUS PHARMACEUTICALS INC | 8 | Q3 2023 | 2.3% |
View Nextech Invest Ltd.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-01 |
| 13F-HR/A | 2022-05-16 |
| 13F-HR | 2022-05-16 |
View Nextech Invest Ltd.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.